School of Medicine
Showing 211-220 of 537 Results
-
Lyn Denend
Academic Prog Prof Mgr, School of Medicine - MDRP'S - Biodesign Program
Current Role at StanfordDirector for Academic Programs, Stanford Biodesign
Lecturer, Stanford Medicine -
Huiqiong Deng, MD, PhD
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Huiqiong Deng is a clinical associate professor of psychiatry. In addition to a medical degree, she earned a PhD, with a major in rehabilitation science and a minor in neuroscience. Specializing in the treatment of alcohol/substance addiction, interventional and cultural psychiatry, her goal is to help each patient along the journey to achieve optimal health and quality of life.
As the co-author of more than a dozen scholarly articles, Dr. Deng’s work has appeared in Psychiatry Research, Journal of Studies on Alcohol and Drugs, American Journal on Addictions, Brain Stimulation, and other publications.
Dr. Deng has won numerous honors and awards such as the National Institute on Drug Abuse Young Investigator Travel Award, the Ruth Fox Scholarship from the American Society of Addiction Medicine, and College on the Problems of Drug Dependence Travel Award for Early Career Investigators. In addition, she was selected to attend the Annual American Psychiatry Association Research Colloquium for Junior Investigators. Since she joined faculty at Stanford, Dr. Deng has received research grant support by the Department of Psychiatry and Behavioral Sciences Innovator Grant Program. -
Jenny Deng
Assistant Clinical Research Coordinator, Dermatology
BioJenny Deng is an Assistant Clinical Research Coordinator for Dr. Jean Tang in the Dermatology department. She received her bachelor’s in science from the University of California, Santa Cruz with a major in Molecular and Cell Developmental Biology. She is also a certified phlebotomy technician with an active license. Jenny was born and raised in San Francisco, and when she is not working, enjoys her spare time traveling, working out, and exploring new restaurants to eat.
-
Dr. Qiwen Deng
Postdoctoral Scholar, Pathology
BioHow fibroblasts participate in the organ fibrosis and whether targeting fibroblasts is a good strategy to reverse fibrosis is still a mystery. We have identified two important immune checkpoints, CD47 and PD-L1, are highly expressed in fibroblasts and blocking CD47 and PD-L1 reversed lung fibrosis. This is a prove of concept that targeting immune regulatory pathways could be an effective therapeutic approach to treat fibrotic diseases. In addition to identifying novel targets for the treatment of fibrosis, I am also interested in the crosstalk between fibroblasts and innate immune cells in the development of fibrosis. Combined with cutting-edge NGS approaches including single cell sequencing, spatial transcriptomics and high-dimensional CyTOF technique, we have identified several potential targets and characterized immune cells landscape in lung fibrosis. In the long run, I will focus on the validation of these targets. Specifically, I will apply gain- and loss-function approaches to investigate their role in fibrosis in vitro and in vivo.
